There is an increasing body of evidence to suggest that attenuated strains of Salmonella can be used as live multivalent vaccine delivery systems for guest antigens from other pathogens. However, the constitutive expression of guest antigens, particularly from eukaryotic pathogens, can result in segregation and loss of the recombinant expression plasmid. To maintain expression of these guest antigens, an in vivo inducible promoter can be used. This offers an attractive alternative to the use of plasmids containing genes that confer antibiotic resistance, which is routinely used in vitro but is not acceptable for clinical applications. The modified Escherichia coli nitrite reductase nir B promoter is induced under conditions of reduced oxygen tension and has been used with great success to direct the expression of guest antigens in vivo (8) . An attenuated S. typhi construct harboring a plasmid containing fragment-C from tetanus toxin (TetC) of Clostridium tetaniunder the transcriptional control of nir B is under evaluation as a combined human typhoid-tetanus vaccine (5) . The Salmonella -TetC expression system has been used to enable the expression of a variety of antigens fused to TetC.
The induction of the nir B promoter has been described using a number of different industrial anaerobic induction regimes. These regimes have proved impractical for scaling down to suit primary research purposes. This report compares expression of antigens from the human malaria parasite Plasmodium falciparumwith TetC as a fusion partner driven from the nir B promoter in aerobic, microaerophilic and anaerobic conditions, using a commercially available small-scale atmosphere generating system. We show that the nir B promoter is inducible under microaerophilic conditions that model those found in lymphoid organs colonized by Salmonella in vivo and so can be used as a tool to predict the efficacy of a multivalent vaccine before administration.
The malarial antigens studied were the C-and N-terminal non-repeat regions of liver stage antigen-1 (LSA-1) (11) . Immune responses to peptides within the N-terminal region are associated with an absence of blood stage parasitemia (1) and with protection against severe malaria (4) . The codon bias of a gene can have a major impact on the expression level of the corresponding protein and hence its immunogenicity in a live bacterial vaccine. Increased expression of TetC after codon optimization may have contributed to the success of the Salmonella -TetC tetanus vaccine (5) . The gene fragments of the malarial antigens used in this study were not codon-optimized for bacterial expression. The use of A+T bases in the genome of P. falciparum, at greater than 80%, is higher than any other organism whose DNA has been characterized (9) . This codon bias is a novel feature of the genome of this protozoan parasite and differs significantly from Salmonella , which has an A+T content of 48%. Hence, it may be predicted that malarial antigens may be expressed at low levels in a S almonell a host.
Vaccine formulations of Salmonella are grown aerobically to a stationary phase. When administered orally, the bacteria persist in the lymphoid organs, such as liver and spleen, until cleared by the host's immune system (5). To further our research on the use of Salmonellaas a vaccine delivery system for malaria antigens, we sought to determine the expression of TetC fusion proteins from a vaccine strain. Previous studies have shown that expression of the lacZreporter gene from nir B increases significantly when Salmonella enter mammalian macrophages in vitro (2) . As direct examination of fusion protein expression in vivo is not feasible, we have developed a method by which expression can be determined from Salmonellagrown in gaseous environments that simulate those found in mammalian tissues. Oxygen levels produced by the microaerophilic atmosphere generated by CampyGen ™ gas sachets (Oxoid, Basingstoke, England, UK) are of a similar range, 4%-8% O 2 , to those that occur in extracellular locations in vivo (3). In support of this simulation of physiological conditions, we found that the use of CampyGen gas sachets sustains the growth of blood stage cultures of P. falciparum (10) . This method of incubation provides a simple, inexpensive and rapid means by which to assess the expression of the TetC malaria fusion proteins and has generated valuable data used to evaluate which constructs to use for immunization.
In these experiments, stationary phase bacteria were either seeded onto LB agar or inoculated into LB broth. The cultures were then placed into an airtight gas jar (Anaerojar ™; Oxoid) into which either an AnaeroGen ™ or CampyGen gas generating sachet was added. The sachets were activated following the manufacturer's instructions to generate anaerobic (<1% O 2 , 9% CO 2 , 90% N 2 ) and microaerophilic (6% O 2 , 8% CO 2 , 86% N 2 ) conditions, respectively. Bacteria were harvested in LB broth by centrifugation, washed in PBS and the amount of bacteria per sample was adjusted to an equivalent level based on A 650 values. Levels of expression of the TetC fusion proteins were determined by SDS-PAGE and Western blotting using polyclonal serum against TetC or specific malarial antigens (7) . Figure 1 shows the levels of expression of the TetC-LSA-1 fusion proteins increased with decreasing oxygen tension for a representative vaccine strain of S. typhimurium. C5 htrA(BRD726) (5). This inverse correlation was also shown for each of three other different attenuated strains of S. typhimurium examined (C5 htrA , SL3261 aroA , C5 aroD ) (data not shown), indicating the probability of high level expression under the microaerophilic conditions that prevail within tissues in vivo. It also provides a formal demonstration that the nir B promoter has an anaerobic optimum. To our knowledge, this is the first time expression of guest antigens from Salmonella not codon-optimized for bacterial expression has been shown under the transcriptional control of the nir B promoter.
Expression of the TetC-LSA-1 fusion proteins under aerobic conditions was weak compared to that of TetC alone (ca. 95% less protein; Figure 1  lanes 1, 4 and 7) . Expression of heterologous recombinant proteins may be limited when the codon usage of the recombinant gene differs from that of the host cell. Induced expression of mRNA encoding proteins with rarely used codons often leads to inefficient translation of the mRNA. This can result in the premature termination of translation and/or poorly expressed levels of the full-length protein. (6) . An investigation of the inducibility of the TetC-LSA-1 fusion proteins was important to decide whether immunizations should proceed.
Our past experience of this vaccine delivery system suggested that significantly increased expression of these antigens in vivo would be required to elicit an immune response. There is currently no method available to determine expression levels of fusion proteins in vivo, although rescue of bacteria, and thus of expression plasmids, may be achieved from host organs to enable an evaluation of plasmid stability. The method described here provides a novel way to determine maximal expression of fusion proteins under microaerophilic conditions similar to those found in host lymphoid organs where invasion by Salmonellatakes place. This provides a useful tool for predicting the in vivo expression levels of a particular guest antigen and for selecting the optimal attenuated vaccine host strain before administration.
The application of the commercial gas generation system to produce anaerobic and microaerophilic atmospheres enabled these experiments to proceed on a small scale and thus produced reproducible data without expert knowledge of large-scale fermenters. The technique may be adapted for growth of other facultatively anaerobic or microaerophilic pathogens for which fusion protein expression from a promoter may be maximally induced under conditions of reduced oxygen tension. In addition to Salmonella , examples of these include the bacteria Listeria , Mycobacterium, Vibrio and Yersinia , and the intracellular protozoa Plasmodium , Leishmania , Toxoplasmaand Trypanosoma .
